Literature DB >> 17285741

In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system.

Brigitta Loretz1, Andreas Bernkop-Schnürch.   

Abstract

It was the purpose of this study to evaluate the potential of different molecular-weight chitosan-EDTA conjugates as a carrier matrix for nanoparticulate gene delivery systems. Covalent binding of EDTA to more than one chitosan chain provides a cross-linked polymer that is anticipated to produce stabilized particles. pDNA/chitosan-EDTA particles, generated via coazervation, were characterized in size and zeta potential by electrophoretic light scattering and electron microscopy. Stability was investigated at different pH values by enzymatic degradation and subsequent gel retardation assay. Lactate dehydrogenase assay was performed to determine toxicity. Furthermore, transfection efficiency into Caco-2 cells was assessed using a beta-galactosidase reporter gene. Chitosan-EDTA produced from low-viscous chitosan with 68% amino groups being modified by the covalent attachment of EDTA showed the highest complexing efficacy resulting in nanoparticles of 43 nm mean size and exhibiting a zeta potential of +6.3 mV. These particles were more stable at pH 8 than chitosan control particles. The cytotoxicity of chitosan-EDTA particles was below 1% over a time period of 4 hours. These new nanoplexes showed 35% improved in vitro transfection efficiency compared with unmodified chitosan nanoparticles. According to these results, the chitosan-EDTA conjugate may be a promising polymer for gene transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17285741      PMCID: PMC2751372          DOI: 10.1208/aapsj080485

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  21 in total

Review 1.  Chitosans for gene delivery.

Authors:  G Borchard
Journal:  Adv Drug Deliv Rev       Date:  2001-11-05       Impact factor: 15.470

2.  Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle.

Authors:  D Favre; N Provost; V Blouin; G Blancho; Y Chérel; A Salvetti; P Moullier
Journal:  Mol Ther       Date:  2001-12       Impact factor: 11.454

Review 3.  Synthetic DNA delivery systems.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

4.  A rapid alkaline extraction method for the isolation of plasmid DNA.

Authors:  H C Birnboim
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability.

Authors:  S Audouy; G Molema; L de Leij; D Hoekstra
Journal:  J Gene Med       Date:  2000 Nov-Dec       Impact factor: 4.565

6.  Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier.

Authors:  I K Park; T H Kim; Y H Park; B A Shin; E S Choi; E H Chowdhury; T Akaike; C S Cho
Journal:  J Control Release       Date:  2001-10-19       Impact factor: 9.776

7.  pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analyses.

Authors:  P Medberry; S Dennis; T Van Hecke; R K DeLong
Journal:  Biochem Biophys Res Commun       Date:  2004-06-25       Impact factor: 3.575

8.  Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles.

Authors:  Karin Corsi; Fatiha Chellat; L'Hocine Yahia; Julio C Fernandes
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

9.  Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.

Authors:  Min Huang; Eugene Khor; Lee-Yong Lim
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 10.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.

Authors:  M A Kay; J C Glorioso; L Naldini
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

View more
  4 in total

1.  Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections.

Authors:  Amany A El-Sharif; Mohamed H M Hussain
Journal:  Curr Microbiol       Date:  2010-10-21       Impact factor: 2.188

Review 2.  Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.

Authors:  Iyyakkannu Sivanesan; Shadma Tasneem; Nazim Hasan; Juhyun Shin; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Polymers (Basel)       Date:  2022-05-24       Impact factor: 4.967

3.  Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin.

Authors:  Mas Jaffri Masarudin; Suzanne M Cutts; Benny J Evison; Don R Phillips; Paul J Pigram
Journal:  Nanotechnol Sci Appl       Date:  2015-12-11

4.  Microwave irradiation-assisted synthesis of a novel crown ether crosslinked chitosan as a chelating agent for heavy metal ions (M(+n)).

Authors:  Awwad A Radwan; Fars K Alanazi; Ibrahim A Alsarra
Journal:  Molecules       Date:  2010-09-06       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.